Reasons for cannabis use in men with and without psychosis

Drug and Alcohol Review
Bob GreenRoss McD Young

Abstract

Psychoses are relatively low prevalence disorders that have a disproportionately negative impact on individuals and society. Cannabis use is one factor that can exacerbate the negative consequences associated with psychotic disorders. Relatively few studies have examined the effects or reasons for using cannabis self-reported by individuals with psychosis. The present study is the first known to compare directly such factors in individuals with and without psychosis, within a single study. At baseline and follow-up participants with psychosis most commonly reported using cannabis for positive mood alteration (36% and 42%), coping with negative affect (27% and 29%) and for social activity reasons (38% and 29%). The control group most commonly reported using cannabis for relaxation (34% and 43%) and social activity reasons (49% and 51%). Participants with psychosis were less likely to report relaxation as the most important effect after use (27%) or expect it at follow-up (49%) compared to the control group (53% and 70%). In both groups, addiction and positive affect enhancement were the composite variable scores correlated most consistently with concurrent amount and frequency of use.

References

May 2, 2012·Issues in Mental Health Nursing·Irene Markman GeisnerJason R Kilmer
May 28, 2010·International Review of Psychiatry·Dan I LubmanD Castle
Feb 20, 2016·Substance Use & Misuse·Emma Chorlton, Ian C Smith
Dec 22, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·A KolliakouR M Murray
Sep 21, 2010·Journal of Psychiatric Research·Alex S CohenDiana W Stewart
Nov 14, 2008·Journal of Substance Abuse Treatment·Scott M Hyman, Rajita Sinha
Jun 5, 2007·Addictive Behaviors·Bob GreenRoss McD Young
Jan 24, 2007·Clinical Psychology Review·Lynsey GreggGillian Haddock
Apr 11, 2012·Acta Psychiatrica Scandinavica·L K ThorntonT J Lewin
Apr 7, 2009·Addictive Behaviors·David J Kavanagh, Jennifer M Connolly
Nov 28, 2013·Clinical Psychology & Psychotherapy·Helen WoodTony Lavender
Sep 2, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·C González-BlanchM Alvarez-Jimenez
May 8, 2015·Journal of Psychoactive Drugs·Jane A FischerJackob M Najman
Dec 30, 2014·European Psychiatry : the Journal of the Association of European Psychiatrists·A KolliakouK Ismail
Nov 12, 2016·The Linacre Quarterly·Ezra Sullivan, Nicanor Austriaco
Sep 11, 2016·The American Journal of Drug and Alcohol Abuse·Rebecca C HannaSubroto Ghose
Dec 23, 2016·The American Journal on Addictions·Thomas SchnellEuphrosyne Gouzoulis-Mayfrank
Oct 24, 2015·The Australian and New Zealand Journal of Psychiatry·Tai R KakeMenetta Te Aonui
Dec 17, 2009·The Australian and New Zealand Journal of Psychiatry·Bart D PetersLieuwe de Haan
Sep 11, 2018·Behavioural Pharmacology·Priscilla P OomenMatthijs G Bossong
Sep 1, 2011·The Journal of Nervous and Mental Disease·Helen E ChildsGraham Turpin
Mar 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Philip R SzeszkoRobert M Bilder
Jul 9, 2008·Drug and Alcohol Review·Leanne HidesRoss McD Young

Citations

Oct 1, 1978·The American Journal of Psychiatry·D A Treffert
Dec 1, 1991·British Journal of Addiction·M W Fischman, R W Foltin
Jan 1, 1989·Schizophrenia Bulletin·M A TestK Ripp
May 1, 1988·Journal of Abnormal Psychology·W M Cox, E Klinger
Feb 1, 1984·Acta Psychiatrica Scandinavica·P Knudsen, T Vilmar
Mar 1, 1995·The Australian and New Zealand Journal of Psychiatry·M BaigentR J Hafner
Jan 1, 1994·The American Journal of Orthopsychiatry·R WarnerH Weinberg
Jan 1, 1997·The Journal of Nervous and Mental Disease·M F BrunetteR E Drake
Dec 12, 1997·Acta Psychiatrica Scandinavica·J Addington, V Duchak
Aug 27, 1998·Schizophrenia Bulletin·I L FowlerT J Lewin
Sep 22, 2001·Psychiatry Research·L N VorugantiA G Awad
Aug 16, 2002·American Journal of Epidemiology·J van OsH Verdoux
Oct 31, 2002·Human Psychopharmacology·J A Costa e Silva
Apr 16, 2003·Schizophrenia Bulletin·Catherine SpencerPatricia T Michie
Dec 9, 2003·Drug and Alcohol Review·Bob GreenRoss McD Young

Related Concepts

Vigilance, Cortical
Self Medication
Harassment, Non-Sexual
Cannabis Dependence
Longitudinal Survey
Cannabis sativa plant
Coping Skills
Comorbidity
Marijuana Abuse
Psychotic Disorders

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

The Australian and New Zealand Journal of Psychiatry
David SchofieldGail Brennan
Acta Psychiatrica Scandinavica
J Addington, V Duchak
The American Journal on Addictions
Santanu GoswamiGagandeep Singh
© 2020 Meta ULC. All rights reserved